Literature DB >> 8229499

Comparative efficacy of two- and five-day courses of ceftriaxone for treatment of severe shigellosis in children.

T Eidlitz-Marcus1, Y H Cohen, M Nussinovitch, I Elian, I Varsano.   

Abstract

Administration of ceftriaxone for 5 days has been shown to be highly efficient in the treatment of severe shigellosis in children. Our study, involving 40 children, demonstrated that a 2-day course of ceftriaxone was as beneficial as a 5-day course and constituted effective therapy for children with severe shigellosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229499     DOI: 10.1016/s0022-3476(05)80868-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  An update on vaccines against Shigella.

Authors:  Shai Ashkenazi; Dani Cohen
Journal:  Ther Adv Vaccines       Date:  2013-09

2.  Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei.

Authors:  I-Fei Huang; Cheng-Hsun Chiu; Mei-Hui Wang; Chan-Yao Wu; Kai-Sheng Hsieh; Christine C Chiou
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 3.  Antibiotics for the treatment of dysentery in children.

Authors:  Beatrix S Traa; Christa L Fischer Walker; Melinda Munos; Robert E Black
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

4.  Genetic characterization of antimicrobial resistance of Shigella flexneri 1c isolates from patients in Egypt and Pakistan.

Authors:  Salwa F Ahmed; John Klena; Tupur Husain; Jesse Monestersky; Amel Naguib; Momtaz O Wasfy
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-05-02       Impact factor: 3.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.